Clinical Trials for Actinium Pharmaceuticals

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Actinium Pharmaceuticals

Clinical Trials (4)

NCT07157514
Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
PHASE2/PHASE3Not yet recruiting
306 participants
Started: Jan 31, 2026 · Completed: Feb 28, 2034
11 conditions1 sponsor0 locations
NCT07015684
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
PHASE1Recruiting
24 participants
Started: Apr 28, 2025 · Completed: Mar 12, 2032
1 condition2 sponsors1 location
NCT06768905
Study of IOMAB-ACT Followed by CAR-T Cell Therapy for Patients Relapsed or Refractory (Diffuse Large B-cell Lymphoma
PHASE1/PHASE2Recruiting
30 participants
Started: Apr 25, 2025 · Completed: May 31, 2030
2 conditions2 sponsors1 location
NCT02665065
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
PHASE3Active, not recruiting
153 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2026
9 conditions1 sponsor24 locations